0001213900-24-059873.txt : 20240708
0001213900-24-059873.hdr.sgml : 20240708
20240708174200
ACCESSION NUMBER: 0001213900-24-059873
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240703
FILED AS OF DATE: 20240708
DATE AS OF CHANGE: 20240708
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Mikhak Zamaneh
CENTRAL INDEX KEY: 0001962453
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39102
FILM NUMBER: 241105919
MAIL ADDRESS:
STREET 1: 1751 RIVER RUN, SUITE 400
STREET 2: C/O TFF PHARMACEUTICALS, INC.
CITY: FORT WORTH
STATE: TX
ZIP: 76107
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: TFF Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001733413
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 824344737
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2600 VIA FORTUNA, SUITE 360
CITY: AUSTIN
STATE: TX
ZIP: 78746
BUSINESS PHONE: 737-802-1973
MAIL ADDRESS:
STREET 1: 2600 VIA FORTUNA, SUITE 360
CITY: AUSTIN
STATE: TX
ZIP: 78746
4
1
ownership.xml
X0508
4
2024-07-03
0
0001733413
TFF Pharmaceuticals, Inc.
TFFP
0001962453
Mikhak Zamaneh
1751 RIVER RUN, SUITE 400
FORT WORTH
TX
76107
0
1
0
0
Chief Medical Officer
0
Common Stock
2024-07-03
4
A
0
10184
0
A
145184
D
Stock Options (Right to Buy)
1.82
2024-07-03
4
A
0
10184
0
A
2025-06-19
2034-07-03
Common stock
10184
10184
D
Represents shares of common stock underlying restricted stock units ("RSUs"). Each RSU entitles its holder to receive one share of common stock of the issuer. The RSUs vest and settle in sixteen equal quarterly installments with a one-year cliff.
One-quarter of the options vest and first become exercisable on June 19, 2025 and the remainder of the options vest and first become exercisable in 12 equal quarterly installments commencing on September 19, 2025.
/s/ Zamaneh Mikhak
2024-07-05